As a worldwide leader in cardiovascular and neuromodulation solutions, we are dedicated to creating meaningful products and therapies that transform lives each and every day. It’s health innovation that truly matters.
LivaNova is a global medical technology company built on decades of experience and a relentless commitment to improve the lives of patients around the world. As a worldwide leader in cardiovascular and neuromodulation solutions, we are dedicated to helping create meaningful products and therapies that transform lives each and every day. It’s health innovation that truly matters.
At LivaNova, we strive to help where it really counts. We put the patient first.
We are committed to improving the lives of patients and families who deal with chronic disease, and we support the healthcare professionals who dedicate their lives to helping them. LivaNova is also dedicated to the highest standards, and we operate at the topmost level of business ethics and compliance.
As a strong, market-leading medical technology and solutions company, we understand the importance of bringing both clinical and economic value to our customers. LivaNova offers a diverse product portfolio with a differentiated pipeline. Our global reach is broad with a presence in more than 100 countries and approximately 4,000 employees.
LivaNova operates as two businesses:
We are a global leader in cardiovascular solutions with an established leadership position in heart-lung machines and recognition as the world’s #1 cardiopulmonary bypass company. Plus, we offer the only truly sutureless aortic valve replacement, Perceval®. Our advanced technologies have made significant contributions to cardiac surgery and provided positive outcomes for many patients who have needed cardiac and cardiopulmonary support.
As pioneers of the VNS (Vagus Nerve Stimulation) Therapy® System, we continue to advance medical device solutions for people affected by drug-resistant epilepsy and treatment-resistant depression. This System is also being studied to validate its ability to deliver Autonomic Regulation Therapy for heart failure. Additionally, we treat obstructive sleep apnea (OSA) with an implantable device that stimulates multiple tongue muscles via the hypoglossal nerve, opening the airway while a patient is sleeping.
Learn about a career at Livanova